title: Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus.
abstract: Autoantibodies are clinically relevant biomarkers for numerous autoimmune disorders. The genetic basis of autoantibody production in systemic lupus erythematosus (SLE) and other autoimmune diseases is poorly understood. In this study, we characterized autoantibody profiles in 1,506 individuals from 229 multiplex SLE pedigrees. There was strong familial aggregation of antinuclear antibodies (ANAs), anti-double-stranded DNA (dsDNA), anti-La/SSB, anti-Ro/SSA, anti-Sm, anti-nRNP (nuclear ribonucleoprotein), IgM antiphospholipid (aPL) antibodies (Abs) and rheumatoid factor (RF) across these families enriched for lupus. We performed genome-wide linkage analyses in an effort to map genes that contribute to the production of the following autoantibodies: Ro/SSA, La/SSB, nRNP, Sm, dsDNA, RF, nuclear and phospholipids. Using an approach to minimize false positives and adjust for multiple comparisons, evidence for linkage was found to anti-La/SSB Abs on chromosome 3q21 (adjusted P=1.9 x 10(-6)), to anti-nRNP and/or anti-Sm Abs on chromosome 3q27 (adjusted P=3.5 x 10(-6)), to anti-Ro/SSA and/or anti-La/SSB Abs on chromosome 4q34-q35 (adjusted P=3.4 x 10(-4)) and to anti-IgM aPL Abs on chromosome 13q14 (adjusted P=2.3 x 10(-4)). These results support the hypothesis that autoantibody production is a genetically complex trait. Identification of the causative alleles will advance our understanding of critical molecular mechanisms that underlie SLE and perhaps other autoimmune diseases.
authors.affiliation: Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
authors.forename: P S
authors.initials: PS
authors.lastname: Ramos
authors.forename: J A
authors.initials: JA
authors.lastname: Kelly
authors.forename: C
authors.initials: C
authors.lastname: Gray-McGuire
authors.forename: G R
authors.initials: GR
authors.lastname: Bruner
authors.forename: A N
authors.initials: AN
authors.lastname: Leiran
authors.forename: C M
authors.initials: CM
authors.lastname: Meyer
authors.forename: B
authors.initials: B
authors.lastname: Namjou
authors.forename: K J
authors.initials: KJ
authors.lastname: Espe
authors.forename: W A
authors.initials: WA
authors.lastname: Ortmann
authors.forename: M
authors.initials: M
authors.lastname: Reichlin
authors.forename: C D
authors.initials: CD
authors.lastname: Langefeld
authors.forename: J A
authors.initials: JA
authors.lastname: James
authors.forename: P M
authors.initials: PM
authors.lastname: Gaffney
authors.forename: T W
authors.initials: TW
authors.lastname: Behrens
authors.forename: J B
authors.initials: JB
authors.lastname: Harley
authors.forename: K L
authors.initials: KL
authors.lastname: Moser
mesh_terms: D001741:Black or African American; D000974:Antibodies, Antinuclear / Q000097:blood; D001323:Autoantibodies / Q000097:blood / Q000145:classification / Q000235:genetics*; D001327:Autoimmune Diseases / Q000235:genetics; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D002874:Chromosome Mapping; D002882:Chromosomes, Human, Pair 13; D002893:Chromosomes, Human, Pair 3; D002894:Chromosomes, Human, Pair 4; D005260:Female; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics* / Q000276:immunology*; D008297:Male; D010375:Pedigree; D044465:White People
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D015415:Biomarkers